We discuss the future of mental health care and the role of psychedelic-assisted therapy, focusing on historical shifts in the acceptance of psychedelics, the importance of safety and regulatory protocols, and comprehensive training for clinicians. We highlight the promise of psychedelics for curative intent and the potential FDA approval of MDMA and psilocybin, emphasizing the significance of mental wellness and preventative mental health care.

read more